A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Michael J. Pishvaian, Rebecca S. Slack, Wei Jiang, A. Ruth He, Jimmy J. Hwang, Amy Hankin, Karen Dorsch-Vogel, Divyesh Kukadiya, Louis M. Weiner, John L. Marshall, Jonathan R. Brody

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences